Camlin Fine Sciences quarterly results and financials

Camlin Fine Sciences (CAMLINFINE)₹78.53+1.34%(9 Nov 2026 close)Specialty Chemicals

Key facts

In the Jun 2026 quarter (consolidated), Camlin Fine Sciences reported sales of ₹519 Cr, up 27.5% from Jun 2025, and net profit of −₹33.91 Cr. For the year to Mar 2026, sales were ₹1,721 Cr and net profit ₹23.94 Cr.

Sales (Jun 2026): ₹519 Cr
Net profit (Jun 2026): −₹33.91 Cr
Sales (FY Mar 2026): ₹1,721 Cr
Net profit (FY Mar 2026): ₹23.94 Cr
EPS (Jun 2026): ₹−1.64
Borrowings (Mar 2026): ₹719 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Camlin Fine Sciences quarterly results

₹ crore unless stated; each column is a quarter.

Camlin Fine Sciences Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	405	385	376	380	416	430	431	407	459	440	424	519
Expenses	380	362	344	351	365	374	369	386	425	419	403	509
Operating Profit	24.92	22.95	30.90	28.91	51.87	55.81	61.83	19.95	32.93	20.95	20.93	8.98
OPM %	6.0%	6.0%	8.0%	8.0%	12.0%	13.0%	14.0%	5.0%	7.0%	4.7%	5.0%	1.8%
Other Income	2.01	2.01	−96.24	−15.02	−151	−8.01	−22.05	0.00	−4.01	−24.06	103	−10.02
Interest	19.93	13.96	15.94	22.94	25.93	33.90	14.96	14.96	18.94	16.96	22.92	13.95
Depreciation	18.99	20.98	12.98	14.99	16.99	13.99	16.99	15.98	18.99	15.99	20.99	18.98
Profit before tax	−11.99	−9.99	−94.05	−23.01	−142	0.00	7.99	−11.01	−9.01	−36.99	79.99	−33.99
Tax %	72.0%	47.1%	−12.9%	48.0%	−18.0%	2,164.0%	98.1%	0.0%	65.0%	0.0%	−8.0%	−1.0%
Exceptional items	0.00	0.00	−101	−15.95	−158	−8.97	−32.89	−7.98	−8.96	−23.90	74.74	−11.96
Net Profit	−20.95	−13.97	−81.80	−34.89	−116	−6.98	0.00	−10.97	−14.95	−36.89	85.77	−33.91
EPS (Rs)	−1.02	−0.62	−4.10	−1.80	−5.32	−0.21	−0.03	−0.52	−0.75	−1.88	4.58	−1.64

Camlin Fine Sciences profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Camlin Fine Sciences Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	488	533	720	891	1,046	1,185	1,409	1,677	1,450	1,626	1,721	1,842
Expenses	396	500	702	816	911	996	1,250	1,467	1,280	1,398	1,600	1,756
Operating Profit	91.79	31.90	15.95	72.80	135	187	157	211	169	226	118	83.79
OPM %	19.0%	6.0%	2.2%	8.0%	13.0%	16.0%	11.0%	13.1%	12.0%	14.0%	7.0%	4.6%
Other Income	−1.01	14.03	12.02	14.03	3.01	5.01	33.05	−4.01	−142	−218	59.11	65.10
Interest	23.91	30.88	31.92	40.90	47.87	41.89	40.86	63.84	69.75	107	82.73	72.77
Depreciation	16.99	21.99	26.98	28.99	32.95	43.98	55.96	62.94	55.91	60.99	70.98	74.95
Profit before tax	49.99	−5.99	−30.99	16.99	58.01	105	93.93	79.99	−99.05	−159	22.99	0.00
Tax %	28.0%	−25.9%	−21.9%	82.0%	49.0%	38.1%	36.1%	50.1%	6.0%	0.0%	−2.0%	—
Exceptional items	−3.98	0.00	0.00	0.00	0.00	0.00	0.00	−4.98	0.00	−7.97	−8.97	29.92
Net Profit	35.91	−3.99	−23.92	2.99	29.94	64.86	59.87	39.86	−105	−157	23.94	0.02
EPS (Rs)	3.29	−0.95	−2.17	0.03	2.22	3.55	3.44	2.95	−4.93	−7.38	1.43	0.31
Dividend payout %	11.9%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Camlin Fine Sciences balance sheet

₹ crore, at each year end.

Camlin Fine Sciences Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	10.02	10.01	10.01	12.02	12.02	12.01	13.02	16.03	16.03	17.02	19.04	19.01
Reserves	125	167	202	358	358	390	630	730	803	846	881	1,020
Borrowings	160	180	330	372	460	538	549	645	800	682	651	719
Other Liabilities	132	123	127	274	256	291	283	398	427	426	469	562
Total Liabilities	426	479	669	1,016	1,087	1,232	1,475	1,789	2,045	1,971	2,020	2,319
Fixed Assets	106	140	201	278	272	306	584	601	858	815	703	886
CWIP	2.99	24.96	7.99	13.98	58.98	179	23.97	215	42.96	45.94	9.99	32.97
Investments	1.01	1.01	19.07	115	11.03	7.02	7.02	7.02	8.03	8.03	61.21	30.10
Other Assets	316	313	442	609	745	740	861	965	1,136	1,102	1,246	1,370
Inventories	136	173	198	238	284	297	319	371	567	539	526	503
Trade receivables	113	74.86	145	205	209	253	270	299	305	284	327	372
Cash & equivalents	19.07	19.06	31.12	48.17	103	65.21	138	142	99.35	94.35	154	154
Total Assets	426	479	669	1,016	1,087	1,232	1,475	1,789	2,045	1,971	2,020	2,319

Camlin Fine Sciences cash flow

₹ crore, for each year.

Camlin Fine Sciences Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	45.94	71.91	−8.98	−14.98	−8.99	85.87	117	145	50.95	139	22.96	81.97
Cash from investing activity	−25.95	−65.87	−69.88	−149	−1.99	−89.75	−133	−248	−125	−65.88	−74.89	−52.88
Cash from financing activity	−15.01	−7.01	91.08	182	26.02	3.01	39.05	136	60.09	−86.09	76.13	−25.01
Net cash flow	4.01	−1.01	13.02	18.03	15.03	−1.01	23.03	32.07	−14.02	−13.02	24.05	4.01
Capex	28.07	67.18	31.06	19.05	69.14	134	84.21	214	144	61.16	42.09	62.08
Free cash flow	18.95	4.99	−38.90	−33.93	−77.84	−47.89	33.92	−67.82	−92.78	78.78	−18.96	19.95
CFO / OP %	68.0%	91.1%	5.0%	−33.0%	10.0%	77.0%	82.0%	111.0%	34.1%	110.0%	27.1%	90.1%

Camlin Fine Sciences ratios

Working-capital days and returns, by year.

Camlin Fine Sciences Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	73	55	98	103	85	87	82	76	65	71	73	78
Inventory days	185	312	278	208	220	205	201	179	256	257	235	200
Days payable	143	170	109	153	126	118	98	111	128	153	179	199
Cash conversion cycle	114	196	266	157	178	173	184	143	192	174	127	78
Working capital days	13	2	−5	20	44	23	56	41	43	52	34	24
ROCE %	28.0%	24.0%	5.0%	0.0%	7.0%	11.0%	13.0%	10.0%	10.0%	8.0%	12.0%	5.0%

Camlin Fine Sciences: frequently asked questions

What are the latest quarterly results of Camlin Fine Sciences?

For the Jun 2026 quarter, Camlin Fine Sciences reported sales of ₹519 Cr, up 27.5% year on year and net profit of −₹33.91 Cr. The operating margin was 1.8%.

What is the annual revenue of Camlin Fine Sciences?

Camlin Fine Sciences' sales for the year to Mar 2026 were ₹1,721 Cr; over the last twelve months they were ₹1,842 Cr.

What is the net profit of Camlin Fine Sciences?

Net profit for the year to Mar 2026 was ₹23.94 Cr, and ₹0.02 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.31.

How much debt does Camlin Fine Sciences have?

Camlin Fine Sciences reported borrowings of ₹719 Cr at Mar 2026, against cash and equivalents of ₹154 Cr.

What is the free cash flow of Camlin Fine Sciences?

Cash from operations was ₹81.97 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹19.95 Cr.

Loading…